Tricyclic urea compounds as JAK2 V617F inhibitors
US12187725B2 · kind B2 · utility
0Cited by
24References
42Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 24, 2023 |
| Grant date | Jan 7, 2025 |
| Priority date | — |
| Expiry date | Aug 24, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present application provides tricyclic urea compounds that modulate the activity of the V617F variant of JAK2, which are useful in the treatment of various diseases, including cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.